Author Question: The purpose of a clinical documentation improvement (CDI) program is to help health care facilities ... (Read 27 times)

plus1

  • Hero Member
  • *****
  • Posts: 676
The purpose of a clinical documentation improvement (CDI) program is to help health care facilities comply with government programs and other initiatives with the goal of improving health care quality. Thus, a CDI specialist initiates concurrent and retrospective reviews of inpatient records to identify __________ provider documentation.
 a. abusive and fraudulent
 b. conflicting, incomplete, or nonspecific
  c. illegible physician queries and
 d. redacted health insurance claims and

Question 2

A physician lists viral pneumonia as the final diagnosis. However, the coder notes that laboratory results state gram-negative bacteria.. There is also documentation of chest pain, fever, and dyspnea due to pneumonia. What should the coder do?
 a. Assign a code to the final diagnosis of viral pneumonia
  b. Code bacterial pneumonia, chest pain, fever, and dyspnea
  c. Query the physician regarding the diagnosis of pneumonia
  d. Report symptom codes for chest pain, fever, and dyspnea



Kedrick2014

  • Sr. Member
  • ****
  • Posts: 359
Answer to Question 1

b

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library